CMV REACTIVATION AFTER STOPPING LETERMOVIR PRIMARY PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS

被引：0

作者：

Chavaz, Lara ^{[1
]}

Royston, Lena ^{[1
]}

Masouridi-Levrat, Stavroula ^{[1
]}

Mamez, Anne-Claire ^{[1
]}

Giannotti, Federica ^{[1
]}

Morin, Sarah ^{[1
]}

Van Delden, Christian ^{[1
]}

Chalandon, Yves ^{[1
]}

Neofytos, Dionysios ^{[1
]}

机构：

[1] Univ Hosp Geneva, Geneva, Switzerland

来源：

BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

O102

引用

下载

页码：93 / 93

页数：1

共 50 条

[11] Cost Effectiveness of Letermovir as Cytomegalovirus Prophylaxis in in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Schelfhout, Jonathan
Jiang, Yiling
Miles, LaStella
Merchant, Sanjay
Graham, Jonathan
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S384 - S384
[12] Letermovir for prophylaxis of cytomegalovirus in allogeneic hematopoietic stem cell recipients
Cho, J. C.
Le, A. D.
Locke, S. C.
DRUGS OF TODAY, 2018, 54 (06) : 361 - 368
[13] Neutrophils Response to Human CMV Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Costa, Martina
Tamassia, Nicola
Ligozzi, Marco
Marini, Olivia
Cassatella, Marco
Tecchio, Cristina
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 479 - 479
[14] Coadministration of letermovir and sirolimus in allogeneic hematopoietic cell transplant recipients
Xue, Elisabetta
Lorentino, Francesca
Clerici, Daniela
Farina, Francesca
Oltolini, Chiara
Giglio, Fabio
Campodonico, Edoardo
Nitti, Rosamaria
Bernardi, Massimo
Corti, Consuelo
Peccatori, Jacopo
Ciceri, Fabio
Lupo Stanghellini, Maria Teresa
Greco, Raffaella
BONE MARROW TRANSPLANTATION, 2022, 57 (01) : 128 - 130
[15] Coadministration of letermovir and sirolimus in allogeneic hematopoietic cell transplant recipients
Elisabetta Xue
Francesca Lorentino
Daniela Clerici
Francesca Farina
Chiara Oltolini
Fabio Giglio
Edoardo Campodonico
Rosamaria Nitti
Massimo Bernardi
Consuelo Corti
Jacopo Peccatori
Fabio Ciceri
Maria Teresa Lupo Stanghellini
Raffaella Greco
Bone Marrow Transplantation, 2022, 57 : 128 - 130
[16] High Dose Valaciclovir As CMV Prophylaxis in Allogeneic Hematopoietic Stem Cell Recipients at High Risk of CMV Reactivation
Douglas, Genevieve
Yong, Michelle K.
Tio, Shio Yen
Chau, Maggie
Sasadeusz, Joe
Slavin, Monica
Xie, Mingdi
Ritchie, David
Chee, Lynette C. Y.
BLOOD, 2020, 136
[17] Efficacy of Letermovir for Prophylaxis of CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation: A Multi Center Retrospective Analysis among Japanese Patients
Mori, Yasuo
Yoshimoto, Goichi
Eto, Tetsuya
Nagafuji, Koji
Iwasaki, Hiromi
Ito, Yoshikiyo
Ohno, Yuju
Kamimura, Tomohiko
Ogawa, Ryosuke
Numata, Akihiko
Kato, Koji
Takenaka, Katsuto
Miyamoto, Toshihiro
Akashi, Koichi
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 469 - 470
[18] Breakthrough CMV Infections on Letermovir Prophylaxis in CMV-Seropositive Allogeneic Hematopoeitic Cell Transplant (allo-HCT) Recipients
Shigle, Terri Lynn
Handy, Victoria Wehr
Foolad, Farnaz
Khawaja, Fareed
Aitken, Samuel L.
Chemaly, Roy F.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
[19] Cost Effectiveness of Letermovir in Prevention of Clinically Significant CMV Infection in CMV Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (04) : 12 - 13
[20] Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Royston, Lena
Masouridi-Levrat, Stavroula
Gotta, Verena
Royston, Eva
Pressacco-Brossier, Caroline
Aad, Yasmine Abi
Tonoli, David
Karmime, Abderrahim
Jayo, Murielle
Van Delden, Christian
Lescuyer, Pierre
Pfister, Marc
Chalandon, Yves
Neofytos, Dionysios
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (08)

← 1 2 3 4 5 →